J Clin Neurol.  2005 Apr;1(1):8-13. 10.3988/jcn.2005.1.1.8.

Current Issues in Migraine Genetics

Affiliations
  • 1Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. kimmanho@snu.ac.kr

Abstract

Migraine often runs in families and is associated with both genetic and environmental factors. Clinical and genetic heterogeneity as well as the influence of environmental factors have hampered the identification of the gene responsible for migraine disorder. Family/twin studies suggest the presence of hereditary susceptibility. Several different types of mutations or association studies with genetic polymorphism in neurotransmitters, inflammatory cytokines, homocysteine metabolism, mitochondria, or other risk genes in cerebrovascular disorders have been reported. Recently, progress of molecular genetics in familial hemiplegic migraine has provided important insights, a channelopathy, and now extending to a growing list of membrane excitability disorders. Further identification of candidate genes for migraine and exploring the correlation between phenotype and genotype are expected in the future for the understanding of migraine pathophysiology.

Keyword

Migraine; Genetics

MeSH Terms

Cerebrovascular Disorders
Channelopathies
Cytokines
Genetic Heterogeneity
Genetics*
Genotype
Homocysteine
Humans
Membranes
Metabolism
Migraine Disorders*
Migraine with Aura
Mitochondria
Molecular Biology
Neurotransmitter Agents
Phenotype
Polymorphism, Genetic
Cytokines
Homocysteine
Neurotransmitter Agents

Cited by  2 articles

Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs
Lami Kang, Soon-Tae Lee, Wooseok Im, Seung Chan Kim, Kim Sung Hun, Byung-Kun Kim, Manho Kim
J Clin Neurol. 2007;3(3):127-132.    doi: 10.3988/jcn.2007.3.3.127.

Association between the G252A Tumor Necrosis Factor-β Gene Polymorphism and Medication-Overuse Headache
Masakazu Ishii, Tomomi Onaya, Hirotaka Katoh, Yuji Kiuchi, Hideyo Kasai, Mitsuru Kawamura, Shunichi Shimizu
J Clin Neurol. 2012;8(4):301-304.    doi: 10.3988/jcn.2012.8.4.301.


Reference

1. Roh JK, Kim JS, Ahn YO. Epidemiological and clinical characteristics of migraine in Korea. J Korean Neurol Assoc. 1997. 15:1–18.
2. Anne D, Elisabeth TL, Marie-Germaine B. The genetics of Migraine. Lancet Neurol. 2002. 1:285–293.
Article
3. Russel MB, Olesen J. Increased familial risk and evidence of a genetic factor in migraine. BMJ. 1995. 311:541–544.
4. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russel MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol. 1999. 45:242–246.
Article
5. Gervil M, Ulrich V, Kyvik KO, Olesen J, Russel MB. Migraine without aura: a population based twin study. Ann Neurol. 1999. 46:606–611.
6. Larsson B, Bille B, Pedersen NL. Genetic influence in headaches: a Swedish twin study. Headache. 1995. 35:513–519.
Article
7. Honkasalo ML, Kaprio J, Winter T, Heikkila K, Sillanpaa M, Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 1995. 35:70–78.
Article
8. Mulder EJ, Van Baal C, Gaist D, Kallela M, Kaprio J, Svensson DA, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 2003. 6:422–431.
Article
9. Russell MB, Iselius L, Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum Genet. 1995. 96:726–730.
Article
10. Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, et al. A susceptibility locus for migraine with aura on chromosome 4q24. Am J Hum Genet. 2002. 70:652–662.
Article
11. Carlsson A, Forsgren L, Nylander PO, Hellman U, Forsman-Semb K, Holmgren G, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology. 2002. 59(11):1804–1807.
Article
12. Bjornsson A, Gudmundsson G, Gudfinnsson E, Hrafnsdottir M, Benedikz J, Skuladottir S, et al. Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet. 2003. 73:986–993.
Article
13. Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, et al. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet. 2003. 72:161–167.
Article
14. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology. 1997. 49:201–206.
Article
15. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, et al. Association between dopamine receptor genes and migraine without aura in Sardinian sample. Neurology. 1998. 51:781–786.
Article
16. Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, et al. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci. 2003. 23:301–305.
Article
17. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, et al. Angiotensin converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 2000. 43:133–136.
Article
18. Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA. Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci. 2001. 186:27–30.
Article
19. Johnson MP, Lea RA, Curtain RP, MacMillan JC, Griffiths LR. An investigation of the 5-HT2C receptor gene as a migraine candidate gene. Am J Med Genet B Neuropsychiatr Genet. 2003. 117:86–89.
20. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology. 2001. 56:1273–1277.
Article
21. McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, et al. Single nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics. 2001. 78:135–149.
Article
22. Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, et al. Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology. 2004. 62:141–143.
Article
23. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5, 10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003. 111:84–90.
Article
24. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000. 96:762–764.
Article
25. Seo JH, Kim HJ, Lee IH, Kim OJ, Choi BO. Association between migraine with aura and both homocysteine and MTHFR C677T polymorphism. J Korean Neurol Assoc. 2004. 22:200–205.
26. Peter SS, Anna A, Reto MA, Jean S. Genetics of migraine: possible links to neurophysiological abnormalities. Headache. 2002. 42:365–377.
Article
27. Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: Significant linkage and localization of a gene to Xq24-28. Hum Genet. 2000. 107:18–23.
Article
28. Lea RA, shephered AG, Curtain RP, Nyholt DR, Quinlan S, Brimage PJ, et al. A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics. 2002. 4:17–22.
Article
29. Griffiths LR, Lea RA, Curtain RP, Quinlan S, Chappell J, MacMillan JC. Localization of migraine susceptibility genes to chromosomes 1q, 19p and Xq. Am J Hum Genet. 2001. 69:suppl. 2007.
30. Chioza B, Osei-Lah A, Nashef L, Suarez-Merino B, Wilkie H, Sham P, et al. Haplotype and linkage disequilibrium analysis to characterise a region in the calcium channel gene CACNA1A associated with idiopathic generalized epilepsy. Eur J Hum Genet. 2002. 10:857–864.
Article
31. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbo A, et al. A gene for familial hemiplegic migraine maps to chromosome19. Nat Genet. 1993. 5:40–45.
Article
32. Maija W, Mari AK, Mikko K, Aarno P. The molecular genetics of migraine. Ann Med. 2004. 36:462–473.
Article
33. Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher CF, et al. Familial hemiplegic migraine mutations increase Ca influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci U S A. 2002. 99:13284–13289.
Article
34. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003. 33:192–196.
Article
35. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-23 an d evidence of further heterogeneity. Ann Neurol. 1997. 42:885–890.
Article
36. Marconi R, De Fusco M, Aridon P, Plewnia K, Rossi M, Carapelli S, et al. Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol. 2003. 53:376–381.
Article
37. Thomsen LL, Ostergaard E, Romer SF, Andersen I, Eriksen MK, Olesen J, et al. Sporadic hemiplegic migraine is an aetiologically heterogenous disorder. Cephalalgia. 2003. 23(9):921–928.
Article
38. Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: soporadic hemiplegic migraine. Neurology. 2003. 60:595–601.
39. Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics. 2001. 78:150–154.
Article
40. Ceroni M, Poloni TE, Tonietti S, Fabozzi D, Uggeti C, Frediani F, et al. Migraine with aura and white matter abnormalities: Notch3 mutation. Neurology. 2000. 54:1869–1871.
Article
41. Cupini LM, Santorelli FM, Iani C, Fariello G, Calabresi P. Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? Headache. 2003. 43:407–409.
Article
42. Roles RG, Adams K, Ito M, Li BU. Maternal inheritance in cyclic vomiting syndrome with neuromuscular disease. Am J Med Genet A. 2003. 120A:474–482.
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr